BSGM

BioSig Technologies, Inc. [BSGM] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

BSGM Stock Summary

Top 10 Correlated ETFs

BSGM


Top 10 Correlated Stocks

BSGM


In the News

11:17 22 Feb 2024 BSGM

BioSig (BSGM) Grows in Arrhythmia Care With Subscription Model

BioSig's (BSGM) subscription model for PURE EP provides electrophysiologists and cardiology departments with flexibility.

08:59 22 Feb 2024 BSGM

Why Is BioSig Technologies (BSGM) Stock Up 19% Today?

BioSig Technologies (NASDAQ: BSGM ) stock is rising higher on Thursday as subsidiary BioSig AI Sciences joins Nvidia's (NASDAQ: NVDA ) Inception program. The Inception program is one that Nvidia uses to select companies with promising developments in the AI and data sciences spaces.

12:54 22 Feb 2024 BSGM

BioSig (BSGM) Inks New Deal to Advance AI in Electrophysiology

The foundation of BioSig's (BSGM) AI medical device platform is set to be built upon integrated healthcare datasets.

11:00 22 Feb 2024 BSGM

The Benefits of Investing in Penny Stocks in the Long Term

Why investing in penny stocks in the long term could be the right choice The post The Benefits of Investing in Penny Stocks in the Long Term  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

03:05 22 Feb 2024 BSGM

4 Hot Penny Stocks To Buy For Under $1 Before Next Week

Penny stocks under $1 to watch before next week. The post 4 Hot Penny Stocks To Buy For Under $1 Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

02:18 22 Feb 2024 BSGM

3 Medical Instruments Stocks With Potential to Outperform

Here we discuss ShockWave Medical (SWAV), CheckCap (CHEK) and Biosig Technologies (BSGM) that have the potential to outperform their industry going forward.

09:33 22 Feb 2024 BSGM

Bluejay Diagnostics (NASDAQ:BJDX), BioSig Technologies (NASDAQ:BSGM) – Sharps Technology And 2 Other Stocks Under $2 Insiders Are Aggressively Buying

The Dow Jones closed higher by more than 400 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.

09:21 22 Feb 2024 BSGM

(BSGM), (LDI) – BioSig Technologies, Reliance Global Group And 2 Other Penny Stocks Insiders Are Aggressively Buying

U.S. stocks recorded losses for the fourth straight session on Wednesday. Investors, meanwhile, focused on some notable insider trades.

08:49 22 Feb 2024 BSGM

BioSig Technologies says Kansas City Heart Institute signs purchase agreement for its PURE EP System

BioSig Technologies Inc has announced that Kansas City Heart Institute at Overland Park Regional Medical Center in Kansas City, USA, has signed a purchase agreement to acquire its PURE EP System. Following its evaluation of BioSig's PURE EP System, Overland Park Regional Medical Center (OPRMC) has signed an agreement to purchase the technology under the terms of the company's new program.

11:23 22 Feb 2024 BSGM

BioSig Technologies gets repeat 'Outperform' tag, $4 price target from Noble Capital

BioSig Technologies Inc has earned a reiterated ‘Outperform' rating and $4 price target from analysts at Noble Capital days after pricing a public offering that generated proceeds of $2.9 million.  The offering was “[a] bit unexpected, timing-wise, but supports PURE EP commercialization,” the firm wrote.

BSGM Financial details

Company Rating
Sell
Market Cap
5.79M
Income
-30M
Revenue
141K
Book val./share
-0.01
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
47
Optionable
No
Shortable
Yes
Earnings
29 Mar 2024
P/E
-0.85
Forward P/E
-0.8
PEG
0.18
P/S
216.59
P/B
-24.29
P/C
29.7
P/FCF
-1.63
Quick Ratio
0.13
Current Ratio
0.27
Debt / Equity
-0.5
LT Debt / Equity
-0.2
-
-
EPS (TTM)
-0.5
EPS next Y
-0.37
EPS next Q
1.58
EPS this Y
-31.91%
EPS next Y
-26.09%
EPS next 5Y
-26.09%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-62.13%
-
-
-
-
SMA20
-66.67%
SMA50
-66.67%
SMA100
-80%
Inst Own
8.31%
Inst Trans
0.98%
ROA
-951%
ROE
-6700%
ROC
38.76%
Gross Margin
81%
Oper. Margin
-20811%
Profit Margin
-21276%
Payout
-
Shs Outstand
9.33M
Shs Float
7.72M
-
-
-
-
Target Price
-
52W Range
0.603-16.5
52W High
-
52W Low
-
RSI
15
Rel Volume
22.31
Avg Volume
63.04K
Volume
1.41M
Perf Week
-61.28%
Perf Month
-90.07%
Perf Quarter
-94.08%
Perf Half Y
-95.01%
-
-
-
-
Beta
1.399
-
-
Volatility
0.19%, 0.92%
Prev Close
-17.55%
Price
0.297
Change
-42.88%

BSGM Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0000.010.01
Net income per share
-1.19-1.64-1.87-0.94-0.64
Operating cash flow per share
-0.71-0.75-0.95-0.79-0.51
Free cash flow per share
-0.73-0.76-0.96-0.8-0.51
Cash per share
0.310.591.010.350.01
Book value per share
0.260.550.880.370.01
Tangible book value per share
0.240.560.890.370
Share holders equity per share
0.260.550.880.370.01
Interest debt per share
00.030.010.020.02
Market cap
619.34M1.23B1.09B747.32M179.06M
Enterprise value
614.89M1.21B1.06B736.31M179.46M
P/E ratio
-35.9-36.12-20.86-23.83-6.57
Price to sales ratio
0001.69K626.07
POCF ratio
-60.39-79.13-40.91-28.31-8.25
PFCF ratio
-58.63-77.68-40.78-27.74-8.19
P/B Ratio
163.01107.8344.4760.53428.37
PTB ratio
163.01107.8344.4760.53428.37
EV to sales
0001.67K627.5
Enterprise value over EBITDA
-35.65-35.13-18.09-21.81-6.65
EV to operating cash flow
-59.96-78.39-39.86-27.89-8.27
EV to free cash flow
-58.21-76.96-39.73-27.33-8.2
Earnings yield
-0.03-0.03-0.05-0.04-0.15
Free cash flow yield
-0.02-0.01-0.02-0.04-0.12
Debt to equity
00.060.010.051.83
Debt to assets
00.050.010.040.19
Net debt to EBITDA
0.260.330.480.33-0.02
Current ratio
3.876.325.745.390.35
Interest coverage
-1.58K0009.09K
Income quality
0.590.450.450.80.8
Dividend Yield
00000
Payout ratio
-0.04-0.01000
Sales general and administrative to revenue
00063.1674.76
Research and developement to revenue
00012.720.35
Intangibles to total assets
0.050.030.010.020.07
Capex to operating cash flow
0.030.0200.020.01
Capex to revenue
000-1.23-0.59
Capex to depreciation
-24.81-5.31-0.16-2.74-0.57
Stock based compensation to revenue
00021.5415.43
Graham number
2.654.56.072.790.38
ROIC
-4.55-2.66-2.08-2.34-14
Return on tangible assets
-3.65-2.45-1.74-2.06-7.17
Graham Net
0.220.490.840.29-0.07
Working capital
3.43M10.8M24.23M11.32M-2.13M
Tangible asset value
3.53M11.51M24.93M12.24M89K
Net current asset value
3.43M10.49M24.23M10.94M-2.59M
Invested capital
00.060.010.051.83
Average receivables
00004.5K
Average payables
00001.43K
Average inventory
0288.85K672.85K1.32M1.11M
Days sales outstanding
000011.49
Days payables outstanding
000018.26
Days of inventory on hand
0003.45K2.15K
Receivables turnover
000031.78
Payables turnover
000019.99
Inventory turnover
0000.110.17
ROE
-4.54-2.99-2.13-2.54-65.24
Capex per share
-0.02-0.010-0.020

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.14-0.16-0.12-0.16-0.06
Operating cash flow per share
-0.11-0.1-0.09-0.07-0.05
Free cash flow per share
-0.11-0.1-0.09-0.07-0.05
Cash per share
0.020.010.020.020.01
Book value per share
0.040.010.030-0.01
Tangible book value per share
0.0400.030-0.02
Share holders equity per share
0.040.010.030-0.01
Interest debt per share
0.020.020.010.010.01
Market cap
288.1M179.06M700.26M878.52M368.57M
Enterprise value
288.09M179.46M699.54M877.88M368.71M
P/E ratio
-11.31-6.39-23.88-19.8-20.17
Price to sales ratio
2.13K1.33K140.05K0368.57K
POCF ratio
-58.24-43.52-123.98-179.47-96.28
PFCF ratio
-57.65-42.92-123-176.69-94.8
P/B Ratio
149.51428.37336.52.53K-349.36
PTB ratio
149.51428.37336.52.53K-349.36
EV to sales
2.13K1.33K139.91K0368.71K
Enterprise value over EBITDA
-45-25.95-95.8-81.16-93.16
EV to operating cash flow
-58.24-43.62-123.86-179.34-96.32
EV to free cash flow
-57.65-43.02-122.88-176.56-94.83
Earnings yield
-0.02-0.04-0.01-0.01-0.01
Free cash flow yield
-0.02-0.02-0.01-0.01-0.01
Debt to equity
0.461.830.331.76-0.5
Debt to assets
0.180.190.130.150.17
Net debt to EBITDA
0-0.060.10.06-0.04
Current ratio
1.220.350.760.60.27
Interest coverage
-6.49K388.781.85K00
Income quality
0.760.590.770.440.95
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
35.3643.731.25K02.82K
Research and developement to revenue
12.848.3212.401.15K
Intangibles to total assets
0.060.070.060.070.09
Capex to operating cash flow
0.010.010.010.020.02
Capex to revenue
-0.37-0.43-90-60
Capex to depreciation
-0.6-0.7-0.54-0.84-0.65
Stock based compensation to revenue
3.9812.66429.80-359
Graham number
0.370.190.30.130.14
ROIC
-1.73-3.6-2.12-6.92-507.79
Return on tangible assets
-1.35-1.84-1.5-2.96-1.6
Graham Net
-0.03-0.07-0.02-0.03-0.05
Working capital
549K-2.13M-664K-1.35M-2.86M
Tangible asset value
1.63M89K1.71M137K-1.24M
Net current asset value
13K-2.59M-1.03M-1.63M-3.05M
Invested capital
0.461.830.331.76-0.5
Average receivables
2.5K7K13K19K17.5K
Average payables
01.43K1.43K00
Average inventory
1.86M1.01M340.5K267K204K
Days sales outstanding
3.33630601.26K
Days payables outstanding
09.51000
Days of inventory on hand
5.07K1.12K000
Receivables turnover
27150.2900.07
Payables turnover
09.47000
Inventory turnover
0.020.08000
ROE
-3.31-16.76-3.52-31.974.33
Capex per share
00000

BSGM Frequently Asked Questions

What is BioSig Technologies, Inc. stock symbol ?

BioSig Technologies, Inc. is a US stock , located in Westport of Ct and trading under the symbol BSGM

What is BioSig Technologies, Inc. stock quote today ?

BioSig Technologies, Inc. stock price is $0.297 today.

Is BioSig Technologies, Inc. stock public?

Yes, BioSig Technologies, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap